A Case Report of Hereditary Angioedema: Challenges in Diagnosis and Management
Keywords:
hereditary, angioedema, diagnosis, managementAbstract
Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder which causes bradykinin mediated angioedema. Although it can be life threatening, HAE may be underdiagnosed due to a lack of awareness of the disease and limited access to laboratory testing. Here, we report a case of HAE which was diagnosed only after the patient was referred for COVID-19 vaccination even though he had been experiencing recurrent angioedema for the past 30 years.References
Wilkerson RG, Moellman JJ. Hereditary angioedema. Emerg Med Clin North Am. 2022;40:99–118.
Jindal AK, Bishnoi A, Dogra S. Hereditary angioedema: Diagnostic algorithm and current treatment concepts. Indian Dermatol Online J. 2021;12(6):796–804.
Minafra FG, Goncalves TR, Alves TM, Pinto JA. The mortality from hereditary angioedema worldwide: A review of the real-world data literature. Clin Rev Allergy Immunol. 2022; 62(1):232-9.
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update. World Allergy Organ J. 2022; 15(3):100627.
Soni P, Kumar V, Alliu S, Shetty V. Hereditary angioedema (HAE): a cause for recurrent abdominal pain. BMJ Case Rep. 2016; 2016: bcr2016217196.
Zafra H. Hereditary angioedema: a review. WMJ. 2022;121(1):48-53.
Kaplan AP, Joseph K. Complement, kinins, and hereditary angioedema: mechanisms of plasma instability when C1 inhibitor is absent. Clinic Rev Allerg Immunol. 2016;51:207–15.
Abdulkarim A, Craig TJ. Hereditary angioedema. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
Fijen LM, Levi M, Cohn DM. COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema. J Allergy Clin Immunol Pract 2021;9(11):4156-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.